Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, spoke on antibiotic use and other risk factors for the development of Clostridioides difficile infection.
Risk factors for the development of Clostridioides difficile infection (CDI) include antibiotic use, elderly age, proton pump inhibitor (PPI) use, and immunosuppression, with burden of disease ranging from mild to fulminant, said Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital.
Transcript
Can you speak on risk factors for the development of CDI in the hospital setting and the associated burden of disease for those infected?
Unfortunately, C difficile remains at epidemic levels. It is the most common cause of health care–associated infection in the United States, and there are several risk factors for a primary infection. The main risk factor still remains antibiotic use, and I often get asked, well, what's a good antibiotic or a safe antibiotic? And unfortunately, there isn't one.
All antibiotics portend some risk for CDI, although certainly some, such as clindamycin, have a higher risk than others. So, we really want to do antibiotic stewardship and avoid unnecessary antibiotic use. Other risk factors include elderly age, PPI [proton pump inhibitor] use, and immunosuppression.
So, with regards to the burden of disease, there is a real range. Disease can be asymptomatic to mild to fulminant. And so generally speaking, when we think about disease, we have categories based on our guidance. So, those with nonsevere disease are typically those with diarrheal illness, who are otherwise OK and out of the hospital. Those with severe disease are typically hospitalized patients who are having more profound diarrhea and may be exhibiting signs of dehydration, such as kidney failure. And then patients with fulminant disease can be critically ill and in the ICU [intensive care unit], and already have evidence of end-organ damage, such as very low blood pressure, and needing medication support for that blood pressure.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Following Roe v Wade Overturn, Research Focuses on Male Contraceptives
May 6th 2024Stephanie T. Page, MD, PhD, UW Medicine Diabetes Institute, presented on ongoing research and growing interest in new male contraceptive options, such as an oral pill and a hormonal transdermal gel, at the American Urological Association 2024 Annual Meeting.
Read More